ESMO 2024 Roundup: A Lot Of Stumbles, But There Are New Signs Of Life
The recent ESMO 2024 data highlighted significant advancements in immunotherapy. Check out the results from Merck, BMY, ...
ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress
Combination of masofaniten plus enzalutamide continues to be well tolerated with durable reductions in PSA in patients with ...
Medscape1d
Elinzanetant Shows Significant Improvement in Menopausal Vasomotor and Sleep Symptoms
Targeting two receptors instead of the one targeted by fezolinetant, the new elinzanetant did not show the liver safety ...
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference
Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat ...
Business Insider5d
Immutep’s Efti in Combination with MSD’s KEYTRUDA® Leads to Positive Efficacy with Favourable Safety in First Line Head and Neck Cancer
The ESMO Proferred Paper Oral Presentation slides are available on the Posters & Publications section of Immutep ... 5 ...
Targeted Oncology4d
Phase 2 Trial Highlights Potential of Inavolisib for PIK3CA-Mutated Cancers
Inavolisib showed promise in treating patients with PIK3CA-mutated solid tumors, demonstrating favorable safety and disease ...
Northeast Times2h
Around Town
White endorses Gill State Rep. Martina White endorsed Aizaz Gill, the Republican candidate in the 172nd Legislative District. Gill faces Democrat Sean Dougherty, a lawyer. “Aizaz Gill will be a strong ...
Ribometrix Present Data Supporting Potential of eIF4E Program in KRAS Mutant Non-Small Cell Lung Cancer at ESMO 2024
Ribometrix, a biotechnology company developing small molecule therapeutics that modulate RNA biology, presented the latest ...
CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / September 9, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global ...
EurekAlert!6d
Notable scientific oral abstracts and late-breaking science to be presented at Otolaryngology’s Annual Meeting
The latest research and advances in otolaryngology-head and neck surgery will be presented during the AAO-HNSF 2024 Annual Meeting & OTO EXPOSM in Miami, Florida, September 28 – October 1.
Business Wire7d
Positive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC ...
Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today a ...